Canada markets closed

Nemaura Medical Inc. (NMRD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.7500-0.1500 (-3.85%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.9000
Bid3.5100 x 900
Ask4.2100 x 900
Day's Range3.7500 - 4.0200
52 Week Range2.5000 - 16.5000
Avg. Volume81,825
Market Cap93.483M
Beta (5Y Monthly)-0.91
PE Ratio (TTM)N/A
EPS (TTM)-0.1920
Earnings DateFeb. 11, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
  • Business Wire

    Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer

    Nemaura Medical, Inc. (NASDAQ: NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has appointed Justin Mclarney as Chief Finance Officer, effective September 15, 2020.

  • Business Wire

    Nemaura Medical to Provide US proBEAT™ Launch Update at The LD 500 Virtual Conference

    Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor ("CGM"), together with BEAT™diabetes, a planned health subscription service designed to help people with Type 2 diabetes and prediabetes through personalized lifestyle coaching, today announced that its CEO Dr. Faz Chowdhury will be presenting at the LD 500 investor conference on Thursday, September 3, 2020 at 10:20 a.m. ET.


    (LD Micro) 360 Companies Set to Present this Week

    LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.